Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…
Oxford Health research staff will be attending the Autumn Information Fayre on Wednesday 4 September at the Windmill Centre in Deddington to provide information on dementia research taking place in…
The Mental Health Mission’s Capacity Development (CD) workstream have recently published a report on barriers and enablers to mental health research in the UK, led by Aiste Adomaviciene, Project Manager…
Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants. The first patients are being screened to see if…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
New figures show more than 5,000 people from Buckinghamshire participated in trials in the 12 months from April 2023, including those run at Oxford Health NHS Foundation Trust. They took…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….
Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…
Researchers from the Biomedical Research Centre’s Preventing Multiple Morbidities Theme are looking into whether a ketogenic diet is an effective treatment for treatment-resistant depression (TRD). A ketogenic diet consists of…
A study into Alzheimer’s disease, completed by researchers in the BRC’s Dementia Theme, has found that data gathered from online cognition testing correlates to protein blood biomarker levels associated with…
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
Researchers from the BRC’s Psychological Treatments Theme have contributed to a recent article on the programming characteristics of VR characters and their interpretations by people with paranoia. Paranoia, when a…
University of Oxford and OH BRC supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide…
Academia Meets Industry – Grand Challenges and New Horizons 16th September 2024, Mathematical Institute, Oxford The New Therapeutic Approaches in Translational Mental Health conference will bring together industry, academic and…
Recently, visitors to Oxford’s Westgate Centre were able to learn about the world-class healthcare research taking place in the city. The annual Biomedical Research Centre (BRC) Open Day, hosted by…
New research from Oxford’s Department of Education has revealed the current picture of mental health and diversity support in schools in the Midlands. The research compiled feedback from 48 primary…
MQ Mental Health Research would like to hear form you if you have taken part in a mental health clinical trial that involved testing new medicines. They are putting together…
